Cyprus

At GSK, we unite science, technology and talent to get ahead of disease together.

We prevent and treat disease with specialty medicines, vaccines and general medicines investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; infectious diseases.

Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.

In Cyprus, we work with our partners to deliver medicines and vaccines to patients.

Contact details


Tel: +357 80070017
Email: cy.safety@gsk.com

Back to top

Tel: +357 80070017
Email: cy.safety@gsk.com

Back to top

Please contact Kapakiotis & Papaellinas Ltd
Tel: +357 22899500

Back to top

Please contact: ww.ceeurope-media@gsk.com

Back to top

Exercise your individual rights: privacy.gsk.com/request (HCPs, Consumers/Patients)
Exercise your individual rights: HR.Privacy@gsk.com (Employees, Candidates)

Email questions: CY-MT.CPA@gsk.com

Back to top

Tel: +357 80 070 017

Back to top

EFPIA disclosure

GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations

We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.

We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations.

View our disclosure report for Cyprus